2-(4-Methylcyclohexylidene)acetic acid - CAS 77842-31-0
Catalog: |
BB059210 |
Product Name: |
2-(4-Methylcyclohexylidene)acetic acid |
CAS: |
77842-31-0 |
Synonyms: |
2-(4-methylcyclohexylidene)acetic Acid; (4-Methylcyclohexylidene)acetic acid; 2-(4-Methylcyclohexylidene)aceticacid; 4-Methyl-cyclohexylidenessigsaure |
IUPAC Name: | 2-(4-methylcyclohexylidene)acetic acid |
Description: | 2-(4-Methylcyclohexylidene)acetic acid |
Molecular Weight: | 154.21 |
Molecular Formula: | C9H14O2 |
Canonical SMILES: | CC1CCC(=CC(=O)O)CC1 |
InChI: | InChI=1S/C9H14O2/c1-7-2-4-8(5-3-7)6-9(10)11/h6-7H,2-5H2,1H3,(H,10,11) |
InChI Key: | GHWHMSBKFOPPFM-UHFFFAOYSA-N |
GHS Hazard Statement: | H315 (97.44%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112430183-A | Preparation method of axial chiral 4-substituted cyclohexylidene aryl acetate compound | 20201101 |
CN-112430183-B | Preparation method of axial chiral 4-substituted cyclohexylidene aryl acetate compound | 20201101 |
WO-2017001408-A1 | Pyridazinones as herbicidal compounds | 20150702 |
DE-102013204070-A1 | Use of cosmetically or dermatologically acceptable substituted Michael acceptors for the prevention, reduction or prophylaxis of the tyrosinase activity of the human skin and / or its lightening | 20130311 |
EP-2969029-A2 | Use of cosmetically or dermatologically safe substituted michael acceptors for the prevention, reduction or prophylaxis of the tyrosinase activity of the human skin and/or the lightening of the human skin | 20130311 |
EP-2969029-B1 | Use of cosmetically or dermatologically safe substituted michael acceptors for the prevention, reduction or prophylaxis of the tyrosinase activity of the human skin and/or the lightening of the human skin | 20130311 |
WO-2014139756-A2 | Use of cosmetically or dermatologically safe substituted michael acceptors for the prevention, reduction or prophylaxis of the tyrosinase activity of the human skin and/or the lightening of the human skin | 20130311 |
WO-2012083145-A1 | Glucosamine derivatives | 20101217 |
JP-2004315376-A | Method for producing carboxylic acid ester | 20030411 |
JP-4356344-B2 | Method for producing carboxylic acid ester | 20030411 |
Complexity: | 172 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 154.099379685 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 154.099379685 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 37.3Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS